Cargando…

Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary phytochemical, is capable of attenuating NAFLD development and progression; however, results from clinical studies are inconsist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chongyang, Yuan, Weigang, Fang, Jianguo, Wang, Wenqing, He, Pei, Lei, Jiahui, Wang, Chunxu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999224/ https://www.ncbi.nlm.nih.gov/pubmed/27560482 http://dx.doi.org/10.1371/journal.pone.0161792

Ejemplares similares

Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis
por: Jakubczyk, Karolina, et al.
Publicado: (2020)

Effect of resveratrol on non-alcoholic fatty liver disease
por: Theodotou, Marios, et al.
Publicado: (2019)

Alleviation Effects of Microbial Metabolites from Resveratrol on Non-Alcoholic Fatty Liver Disease
por: Guo, Jingling, et al.
Publicado: (2022)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy
por: Wan, Shuqian, et al.
Publicado: (2018)

Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease
por: Wei, Xiaoyi, et al.
Publicado: (2021)

Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
por: Wan, S., et al.
Publicado: (2019)

Polydatin, A Glycoside of Resveratrol, Is Better Than Resveratrol in Alleviating Non-alcoholic Fatty Liver Disease in Mice Fed a High-Fructose Diet
por: Zhao, Guangshan, et al.
Publicado: (2022)

Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD)
por: Ke, Yong-Chen, et al.
Publicado: (2022)

Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Asghari, Somayyeh, et al.
Publicado: (2018)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023)

Resveratrol inhibits nonalcoholic fatty liver disease in rats
por: Bujanda, Luis, et al.
Publicado: (2008)

Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease
por: Shao, Qi, et al.
Publicado: (2021)

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production
por: Ma, Zhenhua, et al.
Publicado: (2017)

Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Pasdar, Yahya, et al.
Publicado: (2020)

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Yang, Kailin, et al.
Publicado: (2022)

Resveratrol Ameliorates Experimental Alcoholic Liver Disease by Modulating Oxidative Stress
por: Peiyuan, He, et al.
Publicado: (2017)

Resveratrol supplementation into extender protects against cryodamage in dog post-thaw sperm
por: BANG, Seonggyu, et al.
Publicado: (2021)

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Resveratrol Supplementation Protects against Nicotine-Induced Kidney Injury
por: Ramalingam, Anand, et al.
Publicado: (2019)

Efficacy of vitamin D supplementation on adult patients with non-alcoholic fatty liver disease: a single-center experience
por: Gad, Ahmed Ibrahim, et al.
Publicado: (2021)

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
por: Darabi, Zahra, et al.
Publicado: (2019)

The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial
por: Rezaei, Seyed Mohammad Amin, et al.
Publicado: (2023)

Effect of resveratrol on alcohol-induced mortality and liver lesions in mice
por: Bujanda, Luis, et al.
Publicado: (2006)

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
por: Yang, Jinchunzi, et al.
Publicado: (2019)

The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease
por: Zhang, Cheng, et al.
Publicado: (2020)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

Protection role of resveratrol against alcohol-induced heart defect in zebrafish embryos
por: Wang, Feng, et al.
Publicado: (2019)

Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial
por: Cansanção, Kátia, et al.
Publicado: (2020)

A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine
por: Dzator, Jemima S. A., et al.
Publicado: (2022)

Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia
por: Ding, Jian, et al.
Publicado: (2017)

Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation
por: Pani, Arianna, et al.
Publicado: (2020)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)

Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review
por: Zhou, Qian, et al.
Publicado: (2022)

Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: He, Zhangya, et al.
Publicado: (2021)

Maternal One-Carbon Supplement Reduced the Risk of Non-Alcoholic Fatty Liver Disease in Male Offspring
por: Peng, Hui, et al.
Publicado: (2022)

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
por: Barchetta, Ilaria, et al.
Publicado: (2016)

Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial
por: Sun, Yuanlong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9cd86868i7hud5o1n9cdmdkf6d